Gencor’s fenugreek extract obtains health claim approval from Health Canada

February 5, 2020

Gencor received four approved claims from Health Canada for its standardized fenugreek extract called Libifem. 

Gencor (Irvine, CA) received four approved claims from Health Canada for its standardized fenugreek extract called Libifem. The claims, based on clinical data include:

• Helps increase women’s sexual desire
• Helps support women’s healthy sex drive and libido
• Helps promote women’s sexual arousal
• May help reduce menopausal symptoms such as hot flashes and night sweats

"Receiving all four health claims further validates our research on Libifem and its ability to help reduce menopausal symptoms and promote healthy sexual activity," said Chase Shryoc, Gencor's vice president of sales and business development, in a press release. "Libifem is proving to be a well-rounded ingredient for women. We are currently conducting clinical trials to see its potential benefits for women in sports nutrition applications."

Libifem is GRAS and can be easily incorporated into a number of applications, including powders, tablets, and capsules. The new claims are only approved for use in Canada.